INBX
Price
$34.35
Change
+$1.88 (+5.79%)
Updated
Oct 13, 04:59 PM (EDT)
Capitalization
498.01M
31 days until earnings call
RAPT
Price
$26.17
Change
-$0.62 (-2.31%)
Updated
Oct 13, 04:59 PM (EDT)
Capitalization
443.05M
Interact to see
Advertisement

INBX vs RAPT

Header iconINBX vs RAPT Comparison
Open Charts INBX vs RAPTBanner chart's image
Inhibrx Biosciences
Price$34.35
Change+$1.88 (+5.79%)
Volume$820
Capitalization498.01M
RAPT Therapeutics
Price$26.17
Change-$0.62 (-2.31%)
Volume$1.92K
Capitalization443.05M
INBX vs RAPT Comparison Chart in %
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. RAPT commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Buy and RAPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 14, 2025
Stock price -- (INBX: $32.47 vs. RAPT: $26.79)
Brand notoriety: INBX and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 382% vs. RAPT: 93%
Market capitalization -- INBX: $498.01M vs. RAPT: $443.05M
INBX [@Biotechnology] is valued at $498.01M. RAPT’s [@Biotechnology] market capitalization is $443.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, INBX is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 2 TA indicator(s) are bullish while RAPT’s TA Score has 2 bullish TA indicator(s).

  • INBX’s TA Score: 2 bullish, 6 bearish.
  • RAPT’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, RAPT is a better buy in the short-term than INBX.

Price Growth

INBX (@Biotechnology) experienced а -8.93% price change this week, while RAPT (@Biotechnology) price change was -11.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was +14.42%, and the average quarterly price growth was +81.30%.

Reported Earning Dates

INBX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($498M) has a higher market cap than RAPT($443M). RAPT (111.946) and INBX (110.812) have similar YTD gains . RAPT has higher annual earnings (EBITDA): -111.99M vs. INBX (-155.08M). INBX has more cash in the bank: 187M vs. RAPT (169M). RAPT has less debt than INBX: RAPT (3.16M) vs INBX (107M). INBX has higher revenues than RAPT: INBX (1.4M) vs RAPT (0).
INBXRAPTINBX / RAPT
Capitalization498M443M112%
EBITDA-155.08M-111.99M138%
Gain YTD110.812111.94699%
P/E Ratio0.20N/A-
Revenue1.4M0-
Total Cash187M169M111%
Total Debt107M3.16M3,382%
FUNDAMENTALS RATINGS
RAPT: Fundamental Ratings
RAPT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INBXRAPT
RSI
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVGX17.28N/A
N/A
Lord Abbett International Growth R6
BNIEX12.27N/A
N/A
UBS International Sustainable Equity A
JHDCX19.47N/A
N/A
JPMorgan Hedged Equity 2 C
GGGPX45.55N/A
N/A
Goldman Sachs Large Cap Equity P
FIZRX37.34N/A
N/A
Macquarie Opportunity R

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been closely correlated with JBPHF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if RAPT jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-10.74%
JBPHF - RAPT
79%
Closely correlated
N/A
AXON - RAPT
48%
Loosely correlated
-4.22%
TRAW - RAPT
45%
Loosely correlated
-3.83%
AGIO - RAPT
41%
Loosely correlated
-4.29%
KROS - RAPT
39%
Loosely correlated
-2.61%
More